We are live on ! Find out more
AC

AXQ Capital Portfolio holdings

AUM $777M
1-Year Est. Return 9.87%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+9.87%
3 Year Est. Return
+23.94%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$310M
AUM Growth
+$60.3M
Cap. Flow
+$49M
Cap. Flow %
15.81%
Top 10 Hldgs %
7.4%
Holding
817
New
340
Increased
127
Reduced
80
Closed
270

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$2.34M
2
PCG icon
PG&E
PCG
+$2.05M
3
GDDY icon
GoDaddy
GDDY
+$2.02M
4
STZ icon
Constellation Brands
STZ
+$1.93M
5
RHI icon
Robert Half
RHI
+$1.84M

Top Sells

Rank Stock Value
1
NEE icon
NextEra Energy
NEE
+$2.51M
2
CRM icon
Salesforce
CRM
+$2.17M
3
CSX icon
CSX Corp
CSX
+$1.98M
4
DLTR icon
Dollar Tree
DLTR
+$1.79M
5
MLM icon
Martin Marietta Materials
MLM
+$1.74M

Sector Composition

Rank Sector Weight
1 Technology 19.82%
2 Industrials 15.73%
3 Financials 15.52%
4 Consumer Discretionary 13.8%
5 Healthcare 11.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZETA icon
476
Zeta Global
ZETA
$5.38B
$178K 0.06%
+11,469
New +$152K
FLO icon
477
Flowers Foods
FLO
$1.49B
$177K 0.06%
11,085
-1,516
-12% -$26.1K
SD icon
478
SandRidge Energy
SD
$514M
$175K 0.06%
+16,204
New +$165K
CERT icon
479
Certara
CERT
$1.26B
$174K 0.06%
+14,832
New +$175K
BBAI icon
480
BigBear.ai
BBAI
$1.34B
$173K 0.06%
+25,438
New +$91.9K
HOPE icon
481
Hope Bancorp
HOPE
$1.79B
$162K 0.05%
15,138
-7,994
-35% -$80.6K
ALT icon
482
Altimmune
ALT
$552M
$160K 0.05%
+41,282
New +$223K
PL icon
483
Planet Labs
PL
$7.3B
$159K 0.05%
+26,042
New +$106K
SWBI icon
484
Smith & Wesson
SWBI
$651M
$157K 0.05%
+18,033
New +$171K
SANA icon
485
Sana Biotechnology
SANA
$871M
$156K 0.05%
+57,000
New +$118K
IE icon
486
Ivanhoe Electric
IE
$1.45B
$154K 0.05%
+16,959
New +$118K
AEO icon
487
American Eagle Outfitters
AEO
$2.88B
$146K 0.05%
+15,171
New +$163K
ROIV icon
488
Roivant Sciences
ROIV
$24.5B
$146K 0.05%
12,940
-26,586
-67% -$288K
OFIX icon
489
Orthofix Medical
OFIX
$477M
$145K 0.05%
+12,986
New +$161K
BGS icon
490
B&G Foods
BGS
$287M
$144K 0.05%
34,108
+390
+1% +$2.04K
ALHC icon
491
Alignment Healthcare
ALHC
$3.08B
$143K 0.05%
+10,212
New +$164K
UPWK icon
492
Upwork
UPWK
$1.13B
$141K 0.05%
+10,489
New +$151K
ITOS
493
DELISTED
iTeos Therapeutics
ITOS
$138K 0.04%
+13,860
New +$112K
FLYW icon
494
Flywire
FLYW
$1.98B
$137K 0.04%
+11,718
New +$119K
ZVRA icon
495
Zevra Therapeutics
ZVRA
$562M
$135K 0.04%
+15,317
New +$124K
AMRX icon
496
Amneal Pharmaceuticals
AMRX
$5.85B
$134K 0.04%
16,579
-1,720
-9% -$13K
TSHA icon
497
Taysha Gene Therapies
TSHA
$1.68B
$132K 0.04%
+57,000
New +$124K
ORIC icon
498
Oric Pharmaceuticals
ORIC
$1.15B
$131K 0.04%
12,950
+2,889
+29% +$19.4K
PHAT icon
499
Phathom Pharmaceuticals
PHAT
$708M
$131K 0.04%
+13,620
New +$75.4K
EWCZ
500
DELISTED
European Wax Center
EWCZ
$129K 0.04%
+22,874
New +$104K
18 19
20
21 22

Similar funds

PC
Permanens Capital New York $776M AUM 30.08% 1-Year Est. Return
TCM
Twin Capital Management Mcmurray, Pennsylvania $776M AUM 28.34% 1-Year Est. Return
BPIM
Brant Point Investment Management New York $776M AUM 41.18% 1-Year Est. Return
PA
Planning Alternatives Birmingham, Michigan $775M AUM 18.57% 1-Year Est. Return
LA
Lifeworks Advisors Grand Rapids, Michigan $779M AUM 21.25% 1-Year Est. Return
BIA
Biondo Investment Advisors Milford, Pennsylvania $780M AUM 21.03% 1-Year Est. Return
SC
Sylebra Capital Palo Alto, California $774M AUM 56.69% 1-Year Est. Return
SG
SCHF (GPE) Wilson, Wyoming $781M AUM 24.06% 1-Year Est. Return

AXQ Capital's Q2 2025 Portfolio in Review

As of Q2 2025, AXQ Capital held 817 positions worth $310M, up 24% from $249M the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.

AXQ Capital deployed $49M of net new capital in Q2 2025, opening 340 new positions and adding to 127 existing holdings. Its largest new stake was Thermo Fisher Scientific: 5,591 shares worth $2.27M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was MGIC Investment, an estimated $1.65M trimmed.

  • AXQ Capital's largest Q2 2025 buy was Thermo Fisher Scientific: 5,591 shares worth $2.27M.
  • AXQ Capital added most to PG&E in Q2 2025, an estimated $2.05M increase.
  • AXQ Capital's biggest Q2 2025 reduction was MGIC Investment, cutting an estimated $1.65M.
  • AXQ Capital fully exited NextEra Energy in Q2 2025, selling an estimated $2.51M.
  • AXQ Capital's ten largest holdings make up 7.4% of its $310M portfolio in Q2 2025.
  • AXQ Capital opened 340 new positions and closed 270 in Q2 2025.
  • AXQ Capital's portfolio value rose 24% quarter-over-quarter to $310M.

Based on AXQ Capital's 13F filing for Q2 2025, filed 12 Aug 2025.